Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1995
DOI: 10.1097/00004347-199501000-00010
|View full text |Cite
|
Sign up to set email alerts
|

Primary Vulvar Sarcomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
26
0
4

Year Published

1998
1998
2018
2018

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(31 citation statements)
references
References 0 publications
1
26
0
4
Order By: Relevance
“…9 Table 1 summarises the previously described cases together with the cases we report. One of the previously reported cases was thought to be consistent with Ewing's sarcoma, although CD99 was negative, 14 casting doubt on the diagnosis. In several other cases CD99 and/or FLI-1 immunostaining was not undertaken.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…9 Table 1 summarises the previously described cases together with the cases we report. One of the previously reported cases was thought to be consistent with Ewing's sarcoma, although CD99 was negative, 14 casting doubt on the diagnosis. In several other cases CD99 and/or FLI-1 immunostaining was not undertaken.…”
Section: Discussionmentioning
confidence: 93%
“…5 6 EFTs have rarely been described in the vulva and vagina and some of the reported cases have not had molecular or even immunohistochemical-that is, CD99 or FLI-1-confirmation. [7][8][9][10][11][12][13][14][15][16][17][18] In this report, we describe four new cases of EFTs involving the vulva or vagina, all with appropriate immunohistochemical staining patterns and three with molecular confirmation. In doing so, we undertake a review of the previously reported cases of EFTs involving these sites and discuss the differential diagnosis of these neoplasms, which rarely involve the lower part of the female genital tract.…”
mentioning
confidence: 99%
“…The system we have used 4 categorizes all lesions into 6 categories, which include cutaneous vascular malformations, 7-11 cutaneous lesions characterized by dilation of preexisting vessels (including varices, 12-14 angiokeratomas, 15,16 and acquired lymphatic lesions 5,17,18 ), cutaneous vascular hyperplasia, [19][20][21][22][23] benign tumors of vascular endothelium, [24][25][26] malignant vascular tumors, [27][28][29][30][31][32] and cutaneous neoplasms with a significant vascular component. The system we have used 4 categorizes all lesions into 6 categories, which include cutaneous vascular malformations, 7-11 cutaneous lesions characterized by dilation of preexisting vessels (including varices, 12-14 angiokeratomas, 15,16 and acquired lymphatic lesions 5,17,18 ), cutaneous vascular hyperplasia, [19][20][21][22][23] benign tumors of vascular endothelium, [24][25][26] malignant vascular tumors, [27][28][29][30][31][32] and cutaneous neoplasms with a significant vascular component.…”
Section: Discussionmentioning
confidence: 99%
“…Prognosis seems to depend on the size of the lesion, tumor involvement of adjacent tissue, and mitotic activity. Women with lesions greater than 5 cm in diameter, with infiltrating margins, extensive necrosis and with more than five mitotic figures per 10 high power fields, are more likely to have recurrent disease following surgical excision [1,7]. …”
Section: Discussionmentioning
confidence: 99%
“…The most common vulvar sarcomas are leiomyosarcomas, rhabdomyosarcomas, angiosarcomas, neurofibrosarcomas, malignant fibrohistiocytomas, and aggressive angiomyxomas [1]. Among primary vulvar sarcomas, primary extraskeletal mesenchymal chondrosarcomas (EMC) are extremely rare, and have higher rate of misdiagnosis.…”
Section: Introductionmentioning
confidence: 99%